ATE200486T1 - Pyrimidin derivate - Google Patents

Pyrimidin derivate

Info

Publication number
ATE200486T1
ATE200486T1 AT96934545T AT96934545T ATE200486T1 AT E200486 T1 ATE200486 T1 AT E200486T1 AT 96934545 T AT96934545 T AT 96934545T AT 96934545 T AT96934545 T AT 96934545T AT E200486 T1 ATE200486 T1 AT E200486T1
Authority
AT
Austria
Prior art keywords
image
alkyl
alkoxy
hydrogen
compounds
Prior art date
Application number
AT96934545T
Other languages
English (en)
Inventor
Thierry Godel
Claus Riemer
Albrecht Edenhofer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE200486T1 publication Critical patent/ATE200486T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96934545T 1995-10-10 1996-10-04 Pyrimidin derivate ATE200486T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH285595 1995-10-10
CH162596 1996-06-28
PCT/EP1996/004331 WO1997013759A1 (en) 1995-10-10 1996-10-04 Pyrimidin derivatives

Publications (1)

Publication Number Publication Date
ATE200486T1 true ATE200486T1 (de) 2001-04-15

Family

ID=25688204

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934545T ATE200486T1 (de) 1995-10-10 1996-10-04 Pyrimidin derivate

Country Status (14)

Country Link
US (1) US5688798A (de)
EP (1) EP0873317B1 (de)
JP (1) JP3013940B2 (de)
CN (1) CN1199397A (de)
AT (1) ATE200486T1 (de)
BR (1) BR9611037A (de)
CA (1) CA2233502A1 (de)
DE (1) DE69612512T2 (de)
DK (1) DK0873317T3 (de)
ES (1) ES2157463T3 (de)
GR (1) GR3036177T3 (de)
PT (1) PT873317E (de)
TR (1) TR199800636T1 (de)
WO (1) WO1997013759A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232326B1 (en) * 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
JP2005515961A (ja) * 2001-05-22 2005-06-02 ニューロジェン コーポレイション メラニン凝集ホルモン受容体リガンド:置換1−ベンジル−4−アリールピペラジン類似体
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
BRPI0410746A (pt) * 2003-05-19 2006-06-27 Irm Llc compostos e composições imunossupressoras
US20050239791A1 (en) * 2004-04-07 2005-10-27 Hutchison Alan J Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
WO2005110982A2 (en) * 2004-04-07 2005-11-24 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
TW200609219A (en) * 2004-06-17 2006-03-16 Neurogen Corp Aryl-substituted piperazine derivatives
GB0503646D0 (en) * 2005-02-22 2005-03-30 Novartis Ag Organic compounds
GB0508319D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
GB0508314D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
GB0508318D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders
ITFI20110040A1 (it) 2011-03-18 2012-09-19 Paolino Bacci Srl "testa porta-utensili per macchine utensili o centri di lavoro, e macchina comprendente detta testa"
US9732065B2 (en) 2013-05-30 2017-08-15 Sumitomo Dainippon Pharma Co., Ltd. Cyclic aminomethyl pyrimidine derivative
JP7720847B2 (ja) * 2019-12-18 2025-08-08 シーエイチディーアイ ファウンデーション,インコーポレーテッド ハンチンチンタンパク質をイメージングするための化合物及びプローブ

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155572A (en) * 1959-04-13 1964-11-03 Merck & Co Inc Compositions and methods for treating coccidiosis
US3060184A (en) * 1960-11-30 1962-10-23 Merck & Co Inc 1-(4-amino-2-perfluoroalkyl-5-pyrimidinylmethyl)piperazines
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
US5169855A (en) * 1990-03-28 1992-12-08 Du Pont Merck Pharmaceutical Company Piperidine ether derivatives as psychotropic drugs or plant fungicides
US5116846A (en) * 1990-03-28 1992-05-26 Du Pont Merck Pharmaceutical Company N-aralkyl piperidine derivatives as psychotropic drugs
DE9117064U1 (de) * 1991-02-14 1995-07-06 Sirona Dental Systems GmbH, 64625 Bensheim Ventilanordnung in einer zahnärztlichen Absauganlage
AU679040B2 (en) * 1993-03-01 1997-06-19 Merck Sharp & Dohme Limited Pyrrolo-pyridine derivatives as dopamine receptor ligands

Also Published As

Publication number Publication date
JP3013940B2 (ja) 2000-02-28
EP0873317A1 (de) 1998-10-28
MX9802816A (es) 1998-09-30
US5688798A (en) 1997-11-18
WO1997013759A1 (en) 1997-04-17
BR9611037A (pt) 1999-07-06
ES2157463T3 (es) 2001-08-16
TR199800636T1 (xx) 1998-06-22
GR3036177T3 (en) 2001-10-31
JPH11500745A (ja) 1999-01-19
CN1199397A (zh) 1998-11-18
DE69612512D1 (de) 2001-05-17
DE69612512T2 (de) 2002-03-28
EP0873317B1 (de) 2001-04-11
CA2233502A1 (en) 1997-04-17
PT873317E (pt) 2001-09-28
DK0873317T3 (da) 2001-08-06

Similar Documents

Publication Publication Date Title
DE69612512D1 (de) Pyrimidin derivate
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
ATE185792T1 (de) Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen
CA2216796A1 (en) Quinazoline derivatives
NO308848B1 (no) Kromanforbindelse og farmasøytisk preparat som inneholder den
ATE18902T1 (de) Aminosaeurederivate und ihre therapeutischen verwendungen.
NO942953L (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
DK1021456T3 (da) Makrocykliske derivater af erythromysin A og B med 13-leddet ring
CA2234319A1 (en) Fluoro-substituted adamantane derivatives
CA2254117A1 (en) 2,4-diaminopyrimidine derivatives
NO942952D0 (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
CA2210913A1 (en) Antipsychotic 4-(1h-indolyl-1-yl)-1-substituted piperidine derivatives
DE69402935D1 (de) Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
ATE165083T1 (de) N-arylalkylphenylacetamidderivate
DE69319939D1 (de) Aminobenzoesäure Derivate
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
EP0999209A4 (de) 2-sulfamoylbenzoesäure-derivate
DK0629615T3 (da) Indolderivater som glutamatantagonister
NO961719D0 (no) 3-aryl-4-alkyl og 4,5-dialkyl-4H-1,2,4-triazoler som er anvendbare som hukommelsesforsterkere
ES2122521T3 (es) Derivados de 2'-desoxi-5-fluorouridina y sus sales farmaceuticamente aceptables, procedimiento para su preparacion y agentes antitumorales.
ES2068040T3 (es) Sales de 3-(cis-2,6-dimetilpiperidino)-sidnonimina.
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister
DK0514267T3 (da) Hidtil ukendte amidderivater af 1-aminooctahydropyrido(2,1-c)(1,4)oxazin, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee